ClinConnect ClinConnect Logo
Search / Trial NCT07005427

Comparison of Traditional Dysphagia Therapy and Developed Protocol for Dysphagia Patients in Intensive Care Unit

Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 27, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Dysphagia Icu Management Protocol

ClinConnect Summary

This clinical trial is looking at how to treat dysphagia, which means difficulty swallowing, in patients who are in the intensive care unit (ICU). This condition can lead to serious problems like pneumonia and longer hospital stays. The study aims to compare a new treatment plan specifically designed for ICU patients with traditional methods to see which one works better for helping these patients swallow safely.

To participate in the trial, patients must be adults aged 18 or older who have been admitted to the ICU and diagnosed with dysphagia within 72 hours. They need to have a certain level of alertness, but those with pre-existing conditions affecting swallowing or who are expected to stay in the ICU for less than 48 hours will not be included. If eligible, participants can expect to receive either the new treatment approach or the standard therapy while being closely monitored. This study hopes to improve care for patients facing swallowing difficulties in critical situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients (≥18 years) admitted to ICU with confirmed dysphagia by bedside evaluation within 72 hours of admission
  • GCS more then 8
  • Exclusion Criteria:
  • Preexisting neurological disorders affecting swallowing, head and neck cancer, inability to follow commands, expected ICU stay \<48 hours

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Anum Ashraf, PhD*

Principal Investigator

Riphah International University

Nazia Mumtaz, PhD*

Study Director

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported